Barzolvolimab
Barzolvolimab is a biological therapy with 9 clinical trials. Currently 6 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
5
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
6
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of Barzolvolimab in Patients With Atopic Dermatitis
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
A Study of CDX-0159 in Patients With Eosinophilic Esophagitis
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Clinical Trials (9)
A Study of Barzolvolimab in Patients With Atopic Dermatitis
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
A Study of CDX-0159 in Patients With Eosinophilic Esophagitis
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
A Study of Barzolvolimab in Patients With Prurigo Nodularis
A Study of CDX-0159 in Patients With Chronic Inducible Urticaria
A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria
All 9 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 9